147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
NORMAL SEARCH
ADVANCED SEARCH
More posts
BIO22283-D1

Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the expression of LRRC33 by Sézary cells. LRRC33 therefore […]

Read more
BIO22282-D1

Garp as a biomarker and biotarget in t-cell malignancies

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the expression of GARP (LRRC32) by Sézary cells. GARP has […]

Read more
BIO22146-D1

Methods for the diagnosis and treatment of t cell-lymphomas

T-cell lymphomas are a heterogeneous group of malignancies involving T lymphocytes and generally characterized by a poor prognosis. Among them, […]

Read more
BIO22037-D1

Cd38 as a biomarker and biotarget in cell-lymphomas

T-cell lymphomas are a heterogeneous group of malignancies involving T lymphocytes and generally characterized by a poor prognosis. Among them, […]

Read more
BIO21120-D1

Methods for the diagnosis and treatment of t cell-lymphomas ccr8

T-cell lymphomas are a heterogeneous group of malignancies involving T lymphocytes and generally characterized by a poor prognosis. Among them, […]

Read more

You might also be interested in

BIO08305-T1

Novel melanoma antigens

The invention relates to melanoma antigen named MELOE and their use for preventing, treating and […]

Read more
BIO1508601 -T1

Nanobody against ela2a to treat inflammatory bowel

The invention is in the field of therapy of gut inflammatory diseases such as Inflammatory Bowel […]

Read more
MECA11013-T1

Transoesophageal device using high intensity

The present invention relates to a probe comprising: a piezoelectric therapy transducer having an […]

Read more
BIO10412-T1

Recombinant flagellin for preventing and treating

The present invention relates to the use of an optimized truncated flagellin (TLR5 agonist devoided […]

Read more
BIO13284-T1

Methods for expanding a population of alveolar

The present invention relates to methods for expanding a population of alveolar macrophages in a […]

Read more
BIO20216-T1

Use of il-36 inhibitors for the treatment of

Netherton syndrome (NS) is a rare recessive skin disorder caused by loss-of-function mutations in […]

Read more
MECA15483-T1

Medical device for olfactory stimulation

The invention relates to a new medical device for olfactory stimulation of a patient. This device […]

Read more
BIO17685-T1

Antigenic peptides deriving from urocortin 3 and

Despite the notion that human CD8+ T cells are the final mediators of autoimmune ?- cell destruction […]

Read more
BIO17059-T3

Pyk2-based gene therapy gene therapy attenuates

In the present invention it is shown that the inactivation of the Pyk2 gene does not alter […]

Read more
BIO21413-T1

Methods and composition to identify and treat

The present invention relates to a method for treating a subject suffering from a cancer comprising […]

Read more
BIO14015-T1

Anti-neurotensin mab for the treatment of cancer

The present invention relates to a neutralising antibody which is capable of binding to neurotensin […]

Read more
CHIM20164-T1

Triarylpyridine compounds and use thereof for

The invention relates to new bis-triazole 2,4,6-triarylpyridines compounds and their use in the […]

Read more